Stay updated on Imsidolimab in Generalized Pustular Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.

Latest updates to the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This is a routine platform update with no evident changes to the study information.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. No changes to study content or navigation are evident.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page now shows a glossary toggle and adds metadata fields such as Last Update Submitted that Met QC Criteria and Last Update Posted, along with No FEAR Act Data. Versioning was updated from Revision: v3.3.4 to v3.4.0 and some legacy labels were removed, reflecting labeling/UI updates rather than substantive data changes.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the Study Details page with no changes to study data, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA consolidated Locations section is added, listing California, Florida, Indiana, and Michigan; state-specific entries are removed, with the revision tag updated from v3.3.2 to v3.3.3.SummaryDifference0.5%

- Check92 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; no changes to study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Imsidolimab in Generalized Pustular Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.